- Instructions for Authors
- Authorship Policy
- Types of papers
- Editorial procedure
- Manuscript Submission
- Title page
- Scientific style (including important instructions for nucleotide submission and phylogenetic trees)
- Artwork and Illustrations Guidelines
- Supplementary Information (SI)
- Ethical Responsibilities of Authors
- Authorship principles
- Compliance with Ethical Standards
- Conflicts of Interest / Competing Interests
- Research Data Policy and Data Availability Statements
- After acceptance
- Open Choice
- English Language Editing
- Open access publishing
Instructions for Authors
Authorship should incorporate and should be restricted to those who have contributed substantially to the work in one or more of the following categories:
• Conceived of or designed study
• Performed research
• Analyzed data
• Contributed new methods or models
• Wrote the paper
Types of papers
Archives of Virology publishes Original Articles, Brief Reports, Brief Reviews, Annotated Sequence Records, and Special Issues.
Please submit your manuscript in the correct format for each article type. Manuscripts in an incorrect format will be immediately returned to the authors for reformatting.
Every submitted manuscript will be examined by the software "ithenticate" for evidence of plagiarism. Manuscripts that are flagged by this software will be returned to the authors for rewriting.
The journal will accept manuscripts with high-quality electron micrographs of viruses representing new taxa. Genomic variants and papers without proof of novelty will not be considered for peer review. Electron micrographs of poor contrast, unsharp and of small size, as well as micrographs without an indication of dimensions or of the methods used will be rejected. Complete particle descriptions, comparisons with viruses of the same host groups, discussion of relationships and evidence of novelty must be presented.
Papers describing sequences only will only be considered for publication as “Original Articles” or “Brief Reports” if the genomic organization derived from the nucleotide sequences determined differs fundamentally from those of typical members of the virus genus/family. Preferably, the biological significance and function of certain sequence differences should also have been experimentally addressed.
If a manuscript only describes the c•o•m•p•l•e•t•e sequence of a virus for which no or only very limited sequence information is available, the manuscript can be considered for submission in the format of an Annotated Sequence Record (see link ‘Annotated Sequence Records’)”. To facilitate a thorough review of any sequence-based manuscript, sequences generated by the author(s) and described in the manuscript must be either available from GenBank or some other public database, or provided as FASTA (or similar) files together with the submitted manuscript.
Original articles should not exceed 20 pages when printed (a manuscript pages with 3600 characters usually results in one printed page).
Their content should be arranged as follows:
- Title Page (see below)
- Abstract (see below)
- Introduction: The Introduction should supply sufficient background information to establish the context of the present study—it should allow the reader to see the rationale for the present work and to understand and evaluate present results—it should not be too general, nor should it take the form of an exhaustive review of the subject. The Introduction should usually end with one or two sentences that capture the essence of the article: e.g., “In this paper we report the discovery of …”
- Materials and methods: The Materials and methods section should provide sufficient information to permit the work to be repeated. For commonly used methods, a brief description (to avoid constant need to refer to previous publications) and citation of a reference are sufficient. New methods should be described completely, giving sources of unusual chemicals, equipment, and supplies. When large numbers of viruses, mutants, etc., are used in a study, a table may be used to identify sources, properties, etc.
- Results: The Results section should include the outcome of experiments; extensive interpretations of experimental data should be reserved for the Discussion section. Data should be presented in text, tables, or figures—the same data should not be repeated in two or three forms.
- Discussion: The Discussion section should not merely restate the experimental results and immediate conclusions. It should be constructive, interpretive, analytical, and it should establish the relationship between the results obtained and previously published work. It should note problems, such as conflicts with the ideas and data of others, and it should indicate the value of the results for future research.
- Acknowledgments: Acknowledgments of personal assistance and financial support should be stated in concise terms.
- References (see below)
Papers describing sequences only will only be considered for publication as “Original Articles” or “Brief Reports” if the genomic organization derived from the nucleotide sequences determined differs fundamentally from those of typical members of the virus genus/family. Preferably, the biological significance and function of certain sequence differences should also have been experimentally addressed.
If a manuscript only describes the complete sequence of a virus for which no or only very limited sequence information is available, the manuscript can be considered for submission in the format of an Annotated Sequence Record (see link ‘Annotated Sequence Records’)”. To facilitate a thorough review of any sequence-based manuscript, sequences generated by the author(s) and described in the manuscript must be either available from GenBank or some other public database, or provided as FASTA (or similar) files together with the submitted manuscript.
Brief Reports are intended for the presentation of observations that do not warrant a full-length article—they are not meant for preliminary communication of incomplete studies.
- They should not exceed six pages (21000 characters incl. spaces) when printed. This should include all the text, i. e. short Abstract (no more than 100 words), Acknowledgements, References and legends. Division of the text by headings of sections should be omitted, but the general sequence of introduction, materials and methods, results, and discussion may be generally maintained. References should be cited in the same way as in full-length articles. In addition to the text, a maximum of 3 figures or 3 Tables (any combination of 3 such items) can be included.
Annotated Sequence Records
- Annotated Sequence Record papers are intended to draw attention to the availability of c•o•m•p•l•e•t•e viral sequences that are appreciably different from those of known sequenced isolates. Currently, we welcome the molecular description of isolate(s) in the format of an Annotated Sequence Record only if (i) the complete genome sequence of a new or established member of a virus genus is reported for the first time and (ii) the isolate of a virus species under study has unusual molecular features (in terms of differences in sequence identity, genome organization or recombination) and/or differs strikingly from other isolates of the virus in biological properties. Sequences that do not differ from already deposited or published type (reference) sequences by more than random mutations will not be accepted for publication.
- Division of the text by headings of sections should be omitted.
- To facilitate a thorough review of any sequence-based manuscript, sequences generated by the author(s) and described in the manuscript must be either available from GenBank or some other public database, or provided as FASTA (or similar) files together with the submitted manuscript.
- These papers should not exceed two pages in length, when printed (which equals four manuscript pages with 1800 characters each [incl. spaces], including references and figure legends, but excluding the title page and tables) and should not have more than 2 figures or tables.
- The report should give information on the provenance of the virus material (isolated by whom, when and where; together with a reference if available), a reference to the sequence (accession number), an annotated diagram of the sequence information (ORFs, promoters, control sequences etc.), some biological information (host range, pathogenicity, etc.) and the justification for considering why the material is different from previously published isolates.
Reviews are intended to draw together important information from recent publications on subjects of broad interest. They are meant to provide a venue for critical examination and considered opinion of such information.
- Reviews are not meant to be encyclopedic, and should not exceed 20 pages when printed. Reviews may contain figures and tables. References should be cited in the same way as in full-length articles. It is recommended that authors contact a member of the Editorial Board beforehand to determine if a proposed review is likely to be suitable for publication.
- Special issues of Archives of Virology are published to record the proceedings of meetings, symposia, conferences, and congresses on various virologic topics, special issues are also published to record multi-authored treatises and reviews of large, complex virologic topics. In general, special issues are of similar size and page format as the regular issues of Archives of Virology; the number of pages per issue is limited to 240 pages. The Archives of Virology provides full and flexible publishing and marketing services, in timely fashion. Individuals who are organizing a meeting, symposium, conference, or congress, and individuals who would like to organize the writing and publication of a treatise or large review are invited to communicate directly with the Special Issues Editor for further information.
Virology Division News:
Papers published under the rubric Virology Division News (VDN) should describe news and developments that are of interest to the Virology Community, including papers on virus taxonomy, classification, and nomenclature, as well as minutes of IUMS or ICTV committees and obituaries of prominent virologists.
If the authors suggest or discuss novel taxa, the authors should include the following Disclaimer to the article:
- The taxonomic changes suggested/proposed/described here
(i) have not been endorsed by the ICTV Executive Committee,
(ii) may differ from any new taxonomy that is ultimately approved by the ICTV, and
(iii) is presented for discussion only but has no official standing.
Further and if applicable, the authors should add the following sentence: “this article is related to an ongoing taxonomic proposal, submitted to the ICTV but not yet accepted at the time of submission."
Disclaimers: Statements disclaiming governmental or any other type of approval or endorsement will be deleted by the publisher.
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.
Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.
During the online submission process, authors will be prompted for classifications used by the journal to assign editors and reviewers. These classifications should always contain at least one virus family to support the assignment process.
Authors submitting a manuscript should suggest at least two potential reviewers who are acknowledged to have expertise in the subject of the work. These persons must not be or have been members of the institution(s) of the authors or have been associated with them. Being associated in this regard is referring to authors and suggested reviewers publishing together within the last two years.
The current affiliation e-mail address (i.e. hotmail, gmail, yahoo, addresses are not acceptable) as well as an institutional web page address and area of expertise must be provided for each person suggested. Archives of Virology will use such recommended reviewers at its own discretion.
Authors may also indicate up to three reviewers who should not be invited for assessment of the respective paper.
Please make sure your title page contains the following information.
The title should be concise and informative.
- The name(s) of the author(s)
- The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country
- A clear indication and an active e-mail address of the corresponding author
- If available, the 16-digit ORCID of the author(s)
If address information is provided with the affiliation(s) it will also be published.
For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.
Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.
For life science journals only (when applicable)
Trial registration number and date of registration
Trial registration number, date of registration followed by “retrospectively registered”
All manuscripts must contain the following sections under the heading 'Declarations'.
If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.
To be used for all articles, including articles with biological applications
Funding (information that explains whether and by whom the research was supported)
Conflicts of interest/Competing interests (include appropriate disclosures)
Availability of data and material (data transparency)
Code availability (software application or custom code)
Authors' contributions (optional: please review the submission guidelines from the journal whether statements are mandatory)
Additional declarations for articles in life science journals that report the results of studies involving humans and/or animals
Ethics approval (include appropriate approvals or waivers)
Consent to participate (include appropriate statements)
Consent for publication (include appropriate statements)
Please see the relevant sections in the submission guidelines for further information as well as various examples of wording. Please revise/customize the sample statements according to your own needs.
Manuscripts should be submitted in Word.
- Use a normal, plain font (e.g., 10-point Times Roman) for text.
- Use italics for emphasis.
- Use the automatic page numbering function to number the pages.
- Do not use field functions.
- Use tab stops or other commands for indents, not the space bar.
- Use the table function, not spreadsheets, to make tables.
- Use the equation editor or MathType for equations.
Note: If you use Word 2007, do not create the equations with the default equation editor but use the Microsoft equation editor or MathType instead.
- Save your file in doc format. Do not submit docx files.
Manuscripts with mathematical content can also be submitted in LaTeX.
Please use no more than three levels of displayed headings.
Abbreviations should be defined at first mention and used consistently thereafter.
Where abbreviations are used, they should follow the usage established by Chemical Abstracts Service Source Index (Chemical Abstracts Service, The Ohio State University, Columbus, Ohio, U.S.A.).
Standard abbreviations: The following abbreviations do not require definition: DNA; RNA; cDNA; cRNA; rRNA; tRNA; mRNA; DNase; RNase; AMP; ADP; ATP; GTP; ATPase; dGTPase; NAD; NADH; NADP; poly(A); poly(dT); oligo(dT); UV; PFU; CFU; Tris; DEAE; EDTA; HeLa; Vero; MEM; and similarly common terms.
Footnotes on the title page are not given reference symbols. Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data).
Acknowledgments of people, grants, funds, etc. should be placed in a separate section before the reference list. The names of funding organizations should be written in full.
Use a normal, plain font (e.g., 11pt Arial or Calibri with double-spacing) for text.
Scientific style (including important instructions for nucleotide submission and phylogenetic trees)
Availability of viruses, mutants/variants, cells
Submission of a manuscript implies that all viruses, novel mutants and variants, genes, plasmids, vector constructs, and cell lines described in the manuscript will be made freely available for distribution upon request to all qualified members of the scientific community for research purposes.
Nucleotide sequence data
Only in exceptional circumstances will long sequences be published. New nucleotide data must be submitted and deposited in the DDBJ/EMBL/GenBank databases and an accession number obtained before the paper can be accepted for publication. Submission to any one of the three collaborating databanks is sufficient to ensure data entry in all. The accession number should be included in the manuscript e.g., as a footnote on the title page: ‘Note: Nucleotide sequence data reported are available in the DDBJ/EMBL/GenBank databases under the accession number(s)----’. If requested, the database will withhold release of data until publication. The most convenient method for submitting sequence data is by World Wide Web:
or stand-alone submission tool Sequin:
For special types of submissions (e.g., genomes, bulk submissions, etc.) additional submission protocols are available from the above sites.
Papers dealing mainly with sequences will be considered for publication as " Original Article " or " Brief Report " only if the genomic organisation derived from the reported nucleotide sequence differs fundamentally from those of typical members of the virus genus/family and, preferably , also if the biological significance and functions of certain sequence differences have been experimentally addressed. In the absence of biological data , manuscripts describing only sequences can be submitted as an Annotated Sequence Record.
Database Contact Information
DDBJ: Center for Information Biology and DNA Databank of Japan. National Institute of Genetics, 1111 Yata, Mishima, Shizuoka 411-8540, Japan; telephone: +81 559 81 6853; fax: +81 559 81 6849; e-mail: firstname.lastname@example.org; web URL: http://www.ddbj.nig.ac.jp/
EMBL: EMBL Nucleotide Sequence Submissions, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB 10 1SD U.K.; telephone: +44 1223494499; fax: +44 1223 494472; e-mail: E-mail: email@example.com ; web URL: http://www.ebi.ac.uk
GenBank: National Center for Biotechnology Information, National Library of Medicine, Bldg. 38A, Rm 8N-803, Bethesda, MD 20894, U.S.A.; telephone: +1 301 496 2475; fax: +1 301 4809241; e-mail: firstname.lastname@example.org ; web URL: http://www.ncbi.nlm.nih.gov
Nucleic acid sequences of limited length which are the primary subject of a study may be presented freestyle in the most effective format. In exceptional cases, longer nucleic acid sequences may be presented in the following format to conserve space. Submit the sequence as camera-ready copy in lines of 100 bases, using a nonproportional (monospace) font which is easily legible when published at 100 bases per 16 cm line.
Encoded amino acid sequences m
ay be presented, if necessary, immediately above or below the first nucleotide of each codon, by using the standard single-letter amino acid code.
X-ray crystallographic protein structure data
Manuscripts containing new structure determinations (including X-ray amplitudes and phases and derived atomic coordinates) must be accompanied by (an) accession number(s) from an internationally available depository (such as Brookhaven National Laboratory, Upton, NY 11973, U.S.A.). If structure determinations have been submitted to a depository, but an accession number has not yet been assigned, the manuscript can be submitted for review, but it will not be published until (an) accession number(s) is available for insertion into the manuscript.
Each virus should be identified at least once, preferably in the Introduction or Materials and methods section, using formal family, genus, and species terms, and where possible by using a precise strain designation term as developed by an internationally recognized specialty group or culture collection. Please note that the word type is not used before species designations that include a number. Formal terms used for virus families, genera, and species should be those approved by the International Committee on Taxonomy of Viruses (ICTV): King AMQ, Lefkowitz E , Adams MJ, Carstens EB (eds) (2011) Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses, Elsevier, 1338 pages or via http://ictvonline.org/virusTaxonomy.asp. Once formal taxonomic names have been given in a paper, vernacular terms may be used.
Formal taxonomic nomenclature:
In formal taxonomic usage, the first letters of virus order, family, subfamily, genus and species names are capitalized and the terms are printed in italics. Other words in the species name are not capitalized unless they are proper nouns or parts of nouns, for example West Nile virus. In formal usage, the name of the taxon should precede the term for the taxonomic unit; for example: “the family Paramyxoviridae”, “the genus Morbillivirus”. The following represent examples of full formal taxonomic terminology:
1. Order Mononegavirales, family Rhabdoviridae, genus Lyssavirus, species Rabies virus.
2. Family Poxviridae, subfamily Chordopoxvirinae, genus Orthopoxvirus, species Vaccinia virus.
3. Family Picornaviridae, genus Enterovirus, species Enterovirus C.
4. Family Bunyaviridae, genus Tospovirus, species Tomato spotted wilt virus.
Vernacular taxonomic nomenclature:
In formal vernacular usage, virus order, family, subfamily, genus and species names are written in lower case Roman script; they are not capitalized, nor are they printed in italics or underlined. In informal usage, the name of the taxon should not include the formal suffix, and the name of the taxon should follow the term for the taxonomic unit; for example “the picornavirus family”, “the enterovirus genus”.
One particular source of ambiguity in vernacular nomenclature lies in the common use of the same root terms in formal family, genus or species names. Imprecision stems from not being able to easily identify in vernacular usage which hierarchical level is being cited. For example, the vernacular name “paramyxovirus” might refer to the family Paramyxoviridae, the subfamily Paramyxovirinae, or one species in the genus Respirovirus, such as Human parainfluenza virus 1. The solution in vernacular usage is to avoid “jumping” hierarchical levels and to add taxon identification wherever needed. For example, when citing the taxonomic placement of Human parainfluenza virus 1, taxon identification should always be added: “Human parainfluenza virus 1 is a species in the genus Respirovirus, family Paramyxoviridae.” In this example, as is usually the case, adding the information that this virus is also a member of the subfamily Paramyxovirinae and the order Mononegavirales is unnecessary.
It should be stressed that italics and capital letters must be used only when referring to taxonomic categories like species, genera and families. When referring to the virus being studied rather than to the taxonomic group the virus belongs to, the virus name is written in lower case Roman script without capitals, for instance measles virus or tomato chlorosis virus. It is incorrect to write that the species Tobacco mosaic virus has been sequenced or has been isolated from a host plant, since it is only the virus itself, tobacco mosaic virus, that can be handled in this way and has a sequence. Virus species, like genera or families, are man-made taxonomic constructions and do not have hosts, vectors or sequences. On the other hand, it is correct to write that a member (i.e. a virus), a strain or an isolate of the species Tobacco mosaic virus has been isolated or was sequenced. The use of italics when referring to the name of a species signals that it has the status of an official-species recognized by the ICTV.
The 9th ICTV Report (King AMQ, Lefkowitz E , Adams MJ, Carstens EB, Elsevier) or the ICTV web page http://ictvonline.org/virusTaxonomy.asp should be consulted to ascertain which names have been approved as official species names.
Nomenclature of bacteria
Binary names, consisting of a genus and species term (e.g., Escherichia coli), should be used for all bacteria. After the first usage, the genus term should be abbreviated (e.g., E. coli). All taxonomic terms, including genus, species, and subspecies are printed in italics; strain designations are not.
Where appropriate for viral genetic systems (e.g., phenotypes, genotypes, wild-type alleles), the nomenclature recommendations of Demerec et al. should be used: Demerec M, Adelberg EA, Clark AJ et al (1966) A proposal for a uniform nomenclature in bacterial genetics. Genetics 54: 61–76.
Chemical and biochemical nomenclature
The names used for chemical/biochemical compounds should be those recommended in Chemical Abstracts and its indices (Chemical Abstracts Service, The Ohio State University, Columbus, Ohio, U.S.A.), Biochemical Nomenclature and Related Documents (The Biochemical Society, London, U.K.), and the Instructions to Authors of leading biochemistry journals. For enzymes, use terms recommended by The International Union of Biochemistry (1984) Enzyme nomenclature. Academic Press, New York.
Nomenclature for restriction endonucleases should follow standard convention: Roberts RJ (1977) Restriction endonucleases. In: Bukhari AQI, Shapiro JA, Adhya SL (eds) DNA insertion elements, plasmids, and episomes. Cold Spring Harbor Laboratory, New York, pp 757–768.
Nucleotide sequence data
The sequencing strategy employed should be described, and the sequence itself submitted in the form of “camera ready” copy, following standard conventions of the International Union of Biochemistry.
Units of measurement
Standard metric units are used for length, weight, and volume. For these units and for molarity, use standard terms: m, μ, n, and p, for 10–3, 10–6, 10–9, and 10–12, respectively. Use the term k for 103. Avoid compound terms such as mμ or μμ. Avoid the ambiguous term ppm (instead use μg/ml or μg/g). Units of temperature are written as 37°C or 324 K. See standard references for reporting units of illumination, energy, frequency, pressure, etc.
When indicating the mass of viruses, ribosomes, and other biologically complex entities containing different kinds of molecules, the term molecular mass (Mr), not molecular weight, should be used. (Mr is a dimensionless number representing the ratio of the mass of an entity to onetwelfth the mass of an atom of 12C.) When indicating the mass of proteins, carbohydrates, and other complex molecules, the term Mr is also preferred, but molecular weight may be used. It is acceptable, but not necessary, to use the mass unit dalton with the term Mr, but not with the term molecular weight. For example, it is preferred to state that the Mr of the poliovirus virion is 8.58 × 106 and that the Mr of poliovirus protein VP-1 is 33,521.
Isotopically labeled compounds
For simple molecules, isotopic labeling is indicated in the chemical formula or name (e.g., 14CO2, H235SO4, 14C-amino acids, 131I-labeled protein). For complex molecules, the symbol for the isotope introduced is placed in square brackets directly preceding the part of the name that describes the labeled entity (e.g., [14C]urea, SV-40 [32P]DNA, [a-14C]lysine). See Instructions to Authors of leading biochemistry journals for further details.
When virus isolates are derived from patients in clinical studies, do not identify them by using patients’ names or initials, even as part of a strain designation. Do not use hospital identifiers. Instead, use confidentially coded terms. Note: established designations of some viruses and cells that represent patient initials are acceptable — JC virus, BK virus, HeLa cells, etc. Do not use patient group identifiers pertaining to race, address, occupation, etc., unless relevant to the study.
Phylogenetic analysis and phylogenetic tree presentation
Either within the text or within the figure legend, phylogenetic trees should always state;
- The tree type eg Neighbour joining, Maximum likelihood
- Whether it is an unrooted or rooted tree. If rooted, what outgroup was used or whether it was midpoint rooted
- If a substitution model test was undertaken, what model was used
- The branch support used eg aLRT support, posterior branch support, bootstrap support and the number of replicates.
- It should be stated which programs were used to determine the model and construct the phylogenetic tree.
- If any branches were collapsed due to low support values, the cut-off support value should be stated.
- Sequences used to construct phylogenetic trees should have their accession numbers available – either within the tree or as a code in the tree with reference to a table
Within the figure
- substitutions per site bar should be present
- branch support values should be legible, either with text or with symbols depicting a range of support values
- all text should be legible
When new species are being compared to their closest cousins, a phylogenetic analysis is appropriate (Baysian inference, ML, etc.), whereas when appropriate intra-species comparisons of sequences can be done with a pairwise analysis such as NJ.
Reference citations in the text should be identified by numbers in square brackets. Some examples:
1. Negotiation research spans many disciplines .
2. This result was later contradicted by Becker and Seligman .
3. This effect has been widely studied [1-3, 7].
The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text. Do not use footnotes or endnotes as a substitute for a reference list.
The entries in the list should be numbered consecutively.
- Journal article
Gamelin FX, Baquet G, Berthoin S, Thevenet D, Nourry C, Nottin S, Bosquet L (2009) Effect of high intensity intermittent training on heart rate variability in prepubescent children. Eur J Appl Physiol 105:731-738. https://doi.org/10.1007/s00421-008-0955-8
Ideally, the names of all authors should be provided, but the usage of “et al” in long author lists will also be accepted:
Smith J, Jones M Jr, Houghton L et al (1999) Future of health insurance. N Engl J Med 965:325–329
- Article by DOI
Slifka MK, Whitton JL (2000) Clinical implications of dysregulated cytokine production. J Mol Med. https://doi.org/10.1007/s001090000086
South J, Blass B (2001) The future of modern genomics. Blackwell, London
- Book chapter
Brown B, Aaron M (2001) The politics of nature. In: Smith J (ed) The rise of modern genomics, 3rd edn. Wiley, New York, pp 230-257
- Online document
Cartwright J (2007) Big stars have weather too. IOP Publishing PhysicsWeb. http://physicsweb.org/articles/news/11/6/16/1. Accessed 26 June 2007
Trent JW (1975) Experimental acute renal failure. Dissertation, University of California
Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations, see
If you are unsure, please use the full journal title.
For authors using EndNote, Springer provides an output style that supports the formatting of in-text citations and reference list.
Authors preparing their manuscript in LaTeX can use the bibtex file spbasic.bst which is included in Springer’s LaTeX macro package.
- All tables are to be numbered using Arabic numerals.
- Tables should always be cited in text in consecutive numerical order.
- For each table, please supply a table caption (title) explaining the components of the table.
- Identify any previously published material by giving the original source in the form of a reference at the end of the table caption.
- Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.
Artwork and Illustrations Guidelines
Electronic Figure Submission
- Supply all figures electronically.
- Indicate what graphics program was used to create the artwork.
- For vector graphics, the preferred format is EPS; for halftones, please use TIFF format. MSOffice files are also acceptable.
- Vector graphics containing fonts must have the fonts embedded in the files.
- Name your figure files with "Fig" and the figure number, e.g., Fig1.eps.
- Definition: Black and white graphic with no shading.
- Do not use faint lines and/or lettering and check that all lines and lettering within the figures are legible at final size.
- All lines should be at least 0.1 mm (0.3 pt) wide.
- Scanned line drawings and line drawings in bitmap format should have a minimum resolution of 1200 dpi.
- Vector graphics containing fonts must have the fonts embedded in the files.
- Definition: Photographs, drawings, or paintings with fine shading, etc.
- If any magnification is used in the photographs, indicate this by using scale bars within the figures themselves.
- Halftones should have a minimum resolution of 300 dpi.
- Definition: a combination of halftone and line art, e.g., halftones containing line drawing, extensive lettering, color diagrams, etc.
- Combination artwork should have a minimum resolution of 600 dpi.
- Color art is free of charge for online publication.
- If black and white will be shown in the print version, make sure that the main information will still be visible. Many colors are not distinguishable from one another when converted to black and white. A simple way to check this is to make a xerographic copy to see if the necessary distinctions between the different colors are still apparent.
- If the figures will be printed in black and white, do not refer to color in the captions.
- Color illustrations should be submitted as RGB (8 bits per channel).
- To add lettering, it is best to use Helvetica or Arial (sans serif fonts).
- Keep lettering consistently sized throughout your final-sized artwork, usually about 2–3 mm (8–12 pt).
- Variance of type size within an illustration should be minimal, e.g., do not use 8-pt type on an axis and 20-pt type for the axis label.
- Avoid effects such as shading, outline letters, etc.
- Do not include titles or captions within your illustrations.
- All figures are to be numbered using Arabic numerals.
- Figures should always be cited in text in consecutive numerical order.
- Figure parts should be denoted by lowercase letters (a, b, c, etc.).
- If an appendix appears in your article and it contains one or more figures, continue the consecutive numbering of the main text. Do not number the appendix figures,"A1, A2, A3, etc." Figures in online appendices [Supplementary Information (SI)] should, however, be numbered separately.
- Each figure should have a concise caption describing accurately what the figure depicts. Include the captions in the text file of the manuscript, not in the figure file.
- Figure captions begin with the term Fig. in bold type, followed by the figure number, also in bold type.
- No punctuation is to be included after the number, nor is any punctuation to be placed at the end of the caption.
- Identify all elements found in the figure in the figure caption; and use boxes, circles, etc., as coordinate points in graphs.
- Identify previously published material by giving the original source in the form of a reference citation at the end of the figure caption.
Figure Placement and Size
- Figures should be submitted separately from the text, if possible.
- When preparing your figures, size figures to fit in the column width.
- For large-sized journals the figures should be 84 mm (for double-column text areas), or 174 mm (for single-column text areas) wide and not higher than 234 mm.
- For small-sized journals, the figures should be 119 mm wide and not higher than 195 mm.
If you include figures that have already been published elsewhere, you must obtain permission from the copyright owner(s) for both the print and online format. Please be aware that some publishers do not grant electronic rights for free and that Springer will not be able to refund any costs that may have occurred to receive these permissions. In such cases, material from other sources should be used.
In order to give people of all abilities and disabilities access to the content of your figures, please make sure that
- All figures have descriptive captions (blind users could then use a text-to-speech software or a text-to-Braille hardware)
- Patterns are used instead of or in addition to colors for conveying information (colorblind users would then be able to distinguish the visual elements)
- Any figure lettering has a contrast ratio of at least 4.5:1
Supplementary Information (SI)
Springer accepts electronic multimedia files (animations, movies, audio, etc.) and other supplementary files to be published online along with an article or a book chapter. This feature can add dimension to the author's article, as certain information cannot be printed or is more convenient in electronic form.
Before submitting research datasets as Supplementary Information, authors should read the journal’s Research data policy. We encourage research data to be archived in data repositories wherever possible.
- Supply all supplementary material in standard file formats.
- Please include in each file the following information: article title, journal name, author names; affiliation and e-mail address of the corresponding author.
- To accommodate user downloads, please keep in mind that larger-sized files may require very long download times and that some users may experience other problems during downloading.
Audio, Video, and Animations
- Aspect ratio: 16:9 or 4:3
- Maximum file size: 25 GB
- Minimum video duration: 1 sec
- Supported file formats: avi, wmv, mp4, mov, m2p, mp2, mpg, mpeg, flv, mxf, mts, m4v, 3gp
Text and Presentations
- Submit your material in PDF format; .doc or .ppt files are not suitable for long-term viability.
- A collection of figures may also be combined in a PDF file.
- Spreadsheets should be submitted as .csv or .xlsx files (MS Excel).
- Specialized format such as .pdb (chemical), .wrl (VRML), .nb (Mathematica notebook), and .tex can also be supplied.
Collecting Multiple Files
- It is possible to collect multiple files in a .zip or .gz file.
- If supplying any supplementary material, the text must make specific mention of the material as a citation, similar to that of figures and tables.
- Refer to the supplementary files as “Online Resource”, e.g., "... as shown in the animation (Online Resource 3)", “... additional data are given in Online Resource 4”.
- Name the files consecutively, e.g. “ESM_3.mpg”, “ESM_4.pdf”.
- For each supplementary material, please supply a concise caption describing the content of the file.
Processing of supplementary files
- Supplementary Information (SI) will be published as received from the author without any conversion, editing, or reformatting.
In order to give people of all abilities and disabilities access to the content of your supplementary files, please make sure that
- The manuscript contains a descriptive caption for each supplementary material
- Video files do not contain anything that flashes more than three times per second (so that users prone to seizures caused by such effects are not put at risk)
Ethical Responsibilities of Authors
This journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) the journal will follow the COPE guidelines on how to deal with potential acts of misconduct.
Authors should refrain from misrepresenting research results which could damage the trust in the journal, the professionalism of scientific authorship, and ultimately the entire scientific endeavour. Maintaining integrity of the research and its presentation is helped by following the rules of good scientific practice, which include*:
- The manuscript should not be submitted to more than one journal for simultaneous consideration.
- The submitted work should be original and should not have been published elsewhere in any form or language (partially or in full), unless the new work concerns an expansion of previous work. (Please provide transparency on the re-use of material to avoid the concerns about text-recycling (‘self-plagiarism’).
- A single study should not be split up into several parts to increase the quantity of submissions and submitted to various journals or to one journal over time (i.e. ‘salami-slicing/publishing’).
- Concurrent or secondary publication is sometimes justifiable, provided certain conditions are met. Examples include: translations or a manuscript that is intended for a different group of readers.
- Results should be presented clearly, honestly, and without fabrication, falsification or inappropriate data manipulation (including image based manipulation). Authors should adhere to discipline-specific rules for acquiring, selecting and processing data.
- No data, text, or theories by others are presented as if they were the author’s own (‘plagiarism’). Proper acknowledgements to other works must be given (this includes material that is closely copied (near verbatim), summarized and/or paraphrased), quotation marks (to indicate words taken from another source) are used for verbatim copying of material, and permissions secured for material that is copyrighted.
Important note: the journal may use software to screen for plagiarism.
- Authors should make sure they have permissions for the use of software, questionnaires/(web) surveys and scales in their studies (if appropriate).
- Research articles and non-research articles (e.g. Opinion, Review, and Commentary articles) must cite appropriate and relevant literature in support of the claims made. Excessive and inappropriate self-citation or coordinated efforts among several authors to collectively self-cite is strongly discouraged.
- Authors should avoid untrue statements about an entity (who can be an individual person or a company) or descriptions of their behavior or actions that could potentially be seen as personal attacks or allegations about that person.
- Research that may be misapplied to pose a threat to public health or national security should be clearly identified in the manuscript (e.g. dual use of research). Examples include creation of harmful consequences of biological agents or toxins, disruption of immunity of vaccines, unusual hazards in the use of chemicals, weaponization of research/technology (amongst others).
- Authors are strongly advised to ensure the author group, the Corresponding Author, and the order of authors are all correct at submission. Adding and/or deleting authors during the revision stages is generally not permitted, but in some cases may be warranted. Reasons for changes in authorship should be explained in detail. Please note that changes to authorship cannot be made after acceptance of a manuscript.
*All of the above are guidelines and authors need to make sure to respect third parties rights such as copyright and/or moral rights.
Upon request authors should be prepared to send relevant documentation or data in order to verify the validity of the results presented. This could be in the form of raw data, samples, records, etc. Sensitive information in the form of confidential or proprietary data is excluded.
If there is suspicion of misbehavior or alleged fraud the Journal and/or Publisher will carry out an investigation following COPE guidelines. If, after investigation, there are valid concerns, the author(s) concerned will be contacted under their given e-mail address and given an opportunity to address the issue. Depending on the situation, this may result in the Journal’s and/or Publisher’s implementation of the following measures, including, but not limited to:
- If the manuscript is still under consideration, it may be rejected and returned to the author.
- If the article has already been published online, depending on the nature and severity of the infraction:
- an erratum/correction may be placed with the article
- an expression of concern may be placed with the article
- or in severe cases retraction of the article may occur.
The reason will be given in the published erratum/correction, expression of concern or retraction note. Please note that retraction means that the article is maintained on the platform, watermarked “retracted” and the explanation for the retraction is provided in a note linked to the watermarked article.
- The author’s institution may be informed
- A notice of suspected transgression of ethical standards in the peer review system may be included as part of the author’s and article’s bibliographic record.
Authors have an obligation to correct mistakes once they discover a significant error or inaccuracy in their published article. The author(s) is/are requested to contact the journal and explain in what sense the error is impacting the article. A decision on how to correct the literature will depend on the nature of the error. This may be a correction or retraction. The retraction note should provide transparency which parts of the article are impacted by the error.
Suggesting / excluding reviewers
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts. When suggesting reviewers, authors should make sure they are totally independent and not connected to the work in any way. It is strongly recommended to suggest a mix of reviewers from different countries and different institutions. When suggesting reviewers, the Corresponding Author must provide an institutional email address for each suggested reviewer, or, if this is not possible to include other means of verifying the identity such as a link to a personal homepage, a link to the publication record or a researcher or author ID in the submission letter. Please note that the Journal may not use the suggestions, but suggestions are appreciated and may help facilitate the peer review process.
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to.
The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before the work is submitted.
The Publisher does not prescribe the kinds of contributions that warrant authorship. It is recommended that authors adhere to the guidelines for authorship that are applicable in their specific research field. In absence of specific guidelines it is recommended to adhere to the following guidelines*:
All authors whose names appear on the submission
1) made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work;
2) drafted the work or revised it critically for important intellectual content;
3) approved the version to be published; and
4) agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
* Based on/adapted from:
Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate).
The decision whether such information should be included is not only dependent on the scope of the journal, but also the scope of the article. Work submitted for publication may have implications for public health or general welfare and in those cases it is the responsibility of all authors to include the appropriate disclosures and declarations.
All authors are requested to make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards. Please note that journals may have individual policies on (sharing) research data in concordance with disciplinary norms and expectations.
Role of the Corresponding Author
One author is assigned as Corresponding Author and acts on behalf of all co-authors and ensures that questions related to the accuracy or integrity of any part of the work are appropriately addressed.
The Corresponding Author is responsible for the following requirements:
- ensuring that all listed authors have approved the manuscript before submission, including the names and order of authors;
- managing all communication between the Journal and all co-authors, before and after publication;*
- providing transparency on re-use of material and mention any unpublished material (for example manuscripts in press) included in the manuscript in a cover letter to the Editor;
- making sure disclosures, declarations and transparency on data statements from all authors are included in the manuscript as appropriate (see above).
* The requirement of managing all communication between the journal and all co-authors during submission and proofing may be delegated to a Contact or Submitting Author. In this case please make sure the Corresponding Author is clearly indicated in the manuscript.
In absence of specific instructions and in research fields where it is possible to describe discrete efforts, the Publisher recommends authors to include contribution statements in the work that specifies the contribution of every author in order to promote transparency. These contributions should be listed at the separate title page.
Examples of such statement(s) are shown below:
• Free text:
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by [full name], [full name] and [full name]. The first draft of the manuscript was written by [full name] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
• Conceptualization: [full name], …; Methodology: [full name], …; Formal analysis and investigation: [full name], …; Writing - original draft preparation: [full name, …]; Writing - review and editing: [full name], …; Funding acquisition: [full name], …; Resources: [full name], …; Supervision: [full name],….
For review articles where discrete statements are less applicable a statement should be included who had the idea for the article, who performed the literature search and data analysis, and who drafted and/or critically revised the work.
For articles that are based primarily on the student’s dissertation or thesis, it is recommended that the student is usually listed as principal author:
The primary affiliation for each author should be the institution where the majority of their work was done. If an author has subsequently moved, the current address may additionally be stated. Addresses will not be updated or changed after publication of the article.
Changes to authorship
Authors are strongly advised to ensure the correct author group, the Corresponding Author, and the order of authors at submission. Changes of authorship by adding or deleting authors, and/or changes in Corresponding Author, and/or changes in the sequence of authors are not accepted after acceptance of a manuscript.
- Please note that author names will be published exactly as they appear on the accepted submission!
Please make sure that the names of all authors are present and correctly spelled, and that addresses and affiliations are current.
Adding and/or deleting authors at revision stage are generally not permitted, but in some cases it may be warranted. Reasons for these changes in authorship should be explained. Approval of the change during revision is at the discretion of the Editor-in-Chief. Please note that journals may have individual policies on adding and/or deleting authors during revision stage.
Authors are recommended to use their ORCID ID when submitting an article for consideration or acquire an ORCID ID via the submission process.
Deceased or incapacitated authors
For cases in which a co-author dies or is incapacitated during the writing, submission, or peer-review process, and the co-authors feel it is appropriate to include the author, co-authors should obtain approval from a (legal) representative which could be a direct relative.
Authorship issues or disputes
In the case of an authorship dispute during peer review or after acceptance and publication, the Journal will not be in a position to investigate or adjudicate. Authors will be asked to resolve the dispute themselves. If they are unable the Journal reserves the right to withdraw a manuscript from the editorial process or in case of a published paper raise the issue with the authors’ institution(s) and abide by its guidelines.
Authors should treat all communication with the Journal as confidential which includes correspondence with direct representatives from the Journal such as Editors-in-Chief and/or Handling Editors and reviewers’ reports unless explicit consent has been received to share information.
Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals.
Authors should include the following statements (if applicable) in a separate section entitled “Compliance with Ethical Standards” when submitting a paper:
- Disclosure of potential conflicts of interest
- Research involving Human Participants and/or Animals
- Informed consent
Please note that standards could vary slightly per journal dependent on their peer review policies (i.e. single or double blind peer review) as well as per journal subject discipline. Before submitting your article check the instructions following this section carefully.
The corresponding author should be prepared to collect documentation of compliance with ethical standards and send if requested during peer review or after publication.
The Editors reserve the right to reject manuscripts that do not comply with the above-mentioned guidelines. The author will be held responsible for false statements or failure to fulfill the above-mentioned guidelines.
Conflicts of Interest / Competing Interests
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclosure of interests provides a complete and transparent process and helps readers form their own judgments of potential bias. This is not meant to imply that a financial relationship with an organization that sponsored the research or compensation received for consultancy work is inappropriate.
Interests that should be considered and disclosed but are not limited to the following:
Funding: Research grants from funding agencies (please give the research funder and the grant number) and/or research support (including salaries, equipment, supplies, reimbursement for attending symposia, and other expenses) by organizations that may gain or lose financially through publication of this manuscript.
Employment: Recent (while engaged in the research project), present or anticipated employment by any organization that may gain or lose financially through publication of this manuscript. This includes multiple affiliations (if applicable).
Financial interests: Stocks or shares in companies (including holdings of spouse and/or children) that may gain or lose financially through publication of this manuscript; consultation fees or other forms of remuneration from organizations that may gain or lose financially; patents or patent applications whose value may be affected by publication of this manuscript.
It is difficult to specify a threshold at which a financial interest becomes significant, any such figure is necessarily arbitrary, so one possible practical guideline is the following: "Any undeclared financial interest that could embarrass the author were it to become publicly known after the work was published."
Non-financial interests: In addition, authors are requested to disclose interests that go beyond financial interests that could impart bias on the work submitted for publication such as professional interests, personal relationships or personal beliefs (amongst others). Examples include, but are not limited to: position on editorial board, advisory board or board of directors or other type of management relationships; writing and/or consulting for educational purposes; expert witness; mentoring relations; and so forth.
Primary research articles require a disclosure statement. Review articles present an expert synthesis of evidence and may be treated as an authoritative work on a subject. Review articles therefore require a disclosure statement.Other article types such as editorials, book reviews, comments (amongst others) may, dependent on their content, require a disclosure statement. If you are unclear whether your article type requires a disclosure statement, please contact the Editor-in-Chief.
Please note that, in addition to the above requirements, funding information (given that funding is a potential conflict of interest (as mentioned above)) needs to be disclosed upon submission of the manuscript in the peer review system. This information will automatically be added to the Record of CrossMark, however it is not added to the manuscript itself. Under ‘summary of requirements’ (see below) funding information should be included in the ‘Declarations’ section.
Summary of requirements
The above should be summarized in a statement and placed in a ‘Declarations’ section before the reference list under a heading of ‘Funding’ and/or ‘Conflicts of interests’/’Competing interests’. Other declarations include Ethics approval, Consent, Data, Material and/or Code availability and Authors’ contribution statements.
Please see the various examples of wording below and revise/customize the sample statements according to your own needs.
When all authors have the same (or no) conflicts and/or funding it is sufficient to use one blanket statement.
Examples of statements to be used when funding has been received:
- Partial financial support was received from [...]
- The research leading to these results received funding from […] under Grant Agreement No[…].
- This study was funded by […]
- This work was supported by […] (Grant numbers […] and […]
Examples of statements to be used when there is no funding:
- The authors did not receive support from any organization for the submitted work.
- No funding was received to assist with the preparation of this manuscript.
- No funding was received for conducting this study.
- No funds, grants, or other support was received.
Examples of statements to be used when there are interests to declare:
- Financial interests: Author A has received research support from Company A. Author B has received a speaker honorarium from Company Wand owns stock in Company X. Author C is consultant to company Y.
Non-financial interests: Author C is an unpaid member of committee Z.
- Financial interests: The authors declare they have no financial interests.
Non-financial interests: Author A is on the board of directors of Y and receives no compensation as member of the board of directors.
- Financial interests: Author A received a speaking fee from Y for Z. Author B receives a salary from association X. X where s/he is the Executive Director.
Non-financial interests: none.
- Financial interests: Author A and B declare they have no financial interests. Author C has received speaker and consultant honoraria from Company M and Company N. Dr. C has received speaker honorarium and research funding from Company M and Company O. Author D has received travel support from Company O.
Non-financial interests: Author D has served on advisory boards for Company M, Company N and Company O.
Examples of statements to be used when authors have nothing to declare:
- The authors have no relevant financial or non-financial interests to disclose.
- The authors have no conflicts of interest to declare that are relevant to the content of this article.
- All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
- The authors have no financial or proprietary interests in any material discussed in this article.
Authors are responsible for correctness of the statements provided in the manuscript. See also Authorship Principles. The Editor-in-Chief reserves the right to reject submissions that do not meet the guidelines described in this section.
Research Data Policy and Data Availability Statements
A submission to the journal implies that materials described in the manuscript, including all relevant raw data, will be freely available to any researcher wishing to use them for non-commercial purposes, without breaching participant confidentiality.
The journal strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files whenever possible. Please see Springer Nature’s information on recommended repositories.
General repositories - for all types of research data - such as figshare and Dryad may be used where appropriate.
|Mandatory deposition||Suitable repositories|
|DNA and RNA sequences||Genbank|
DNA DataBank of Japan (DDBJ)
EMBL Nucleotide Sequence Database (ENA)
|DNA and RNA sequencing data||NCBI Trace Archive|
NCBI Sequence Read Archive (SRA)
European Variation Archive (EVA)
|Linked genotype and phenotype data||dbGAP|
The European Genome-phenome Archive (EGA)
|Macromolecular structure||Worldwide Protein Data Bank (wwPDB)|
Biological Magnetic Resonance Data Bank (BMRB)
Electron Microscopy Data Bank (EMDB)
|Microarray data (must be MIAME compliant)||Gene Expression Omnibus (GEO)|
|Crystallographic data for small molecules||Cambridge Structural Database|
Where a widely established research community expectation for data archiving in public repositories exists, submission to a community-endorsed, public repository is mandatory. Persistent identifiers (such as DOIs and accession numbers) for relevant datasets must be provided in the paper.
For more information:
All original articles must include a Data availability statement. Data availability statements should include information on where data supporting the results reported in the article can be found including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. By data we mean the minimal dataset that would be necessary to interpret, replicate and build upon the findings reported in the article. We recognise it is not always possible to share research data publicly, for instance when individual privacy could be compromised, and in such instances data availability should still be stated in the manuscript along with any conditions for access.
Data Availability statements can take one of the following forms (or a combination of more than one if required for multiple datasets):
1. The datasets generated during and/or analysed during the current study are available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS]
2. The datasets generated during and/or analysed during the current study are not publicly available due [REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.
3. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
4. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
5. All data generated or analysed during this study are included in this published article [and its supplementary information files].
More examples of template data availability statements, which include examples of openly available and restricted access datasets, are available:
The journal also requires that authors cite any publicly available data on which the conclusions of the paper rely in the manuscript. Data citations should include a persistent identifier (such as a DOI) and should ideally be included in the reference list. Citations of datasets, when they appear in the reference list, should include the minimum information recommended by DataCite and follow journal style. Dataset identifiers including DOIs should be expressed as full URLs.
Research data and peer review
Peer reviewers are encouraged to check the manuscript’s Data availability statement, where applicable. They should consider if the authors have complied with the journal’s policy on the availability of research data, and whether reasonable effort has been made to make the data that support the findings of the study available for replication or reuse by other researchers. Peer reviewers are entitled to request access to underlying data (and code) when needed for them to perform their evaluation of a manuscript.
Authors who need help understanding our data sharing policies, help finding a suitable data repository, or help organising and sharing research data can access our Author Support portal for additional guidance.
Upon acceptance, your article will be exported to Production to undergo typesetting. Once typesetting is complete, you will receive a link asking you to confirm your affiliation, choose the publishing model for your article as well as arrange rights and payment of any associated publication cost.
Once you have completed this, your article will be processed and you will receive the proofs.
Article publishing agreement
Depending on the ownership of the journal and its policies, you will either grant the Publisher an exclusive licence to publish the article or will be asked to transfer copyright of the article to the Publisher.
Offprints can be ordered by the corresponding author.
Online publication of color illustrations is free of charge. For color in the print version, authors will be expected to make a contribution towards the extra costs.
The purpose of the proof is to check for typesetting or conversion errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g., new results, corrected values, title and authorship, are not allowed without the approval of the Editor.
After online publication, further changes can only be made in the form of an Erratum, which will be hyperlinked to the article.
The article will be published online after receipt of the corrected proofs. This is the official first publication citable with the DOI. After release of the printed version, the paper can also be cited by issue and page numbers.
Open Choice allows you to publish open access in more than 1850 Springer Nature journals, making your research more visible and accessible immediately on publication.
Article processing charges (APCs) vary by journal – view the full list
- Increased researcher engagement: Open Choice enables access by anyone with an internet connection, immediately on publication.
- Higher visibility and impact: In Springer hybrid journals, OA articles are accessed 4 times more often on average, and cited 1.7 more times on average*.
- Easy compliance with funder and institutional mandates: Many funders require open access publishing, and some take compliance into account when assessing future grant applications.
It is easy to find funding to support open access – please see our funding and support pages for more information.
*) Within the first three years of publication. Springer Nature hybrid journal OA impact analysis, 2018.
Copyright and license term – CC BY
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under the Creative Commons Attribution License.
English Language Editing
For editors and reviewers to accurately assess the work presented in your manuscript you need to ensure the English language is of sufficient quality to be understood. If you need help with writing in English you should consider:
- Asking a colleague who is a native English speaker to review your manuscript for clarity.
- Visiting the English language tutorial which covers the common mistakes when writing in English.
- Using a professional language editing service where editors will improve the English to ensure that your meaning is clear and identify problems that require your review. Two such services are provided by our affiliates Nature Research Editing Service and American Journal Experts. Springer authors are entitled to a 10% discount on their first submission to either of these services, simply follow the links below.
Please note that the use of a language editing service is not a requirement for publication in this journal and does not imply or guarantee that the article will be selected for peer review or accepted.
If your manuscript is accepted it will be checked by our copyeditors for spelling and formal style before publication.
● 使用专业语言编辑服务，编辑人员会对英语进行润色，以确保您的意思表达清晰，并识别需要您复核的问题。我们的附属机构 Nature Research Editing Service 和合作伙伴 American Journal Experts 即可提供此类服务。
・プロの英文校正サービスを利用する。校正者が原稿の意味を明確にしたり、問題点を指摘し、英語の質を向上させます。Nature Research Editing Service とAmerican Journal Experts の2つは弊社と提携しているサービスです。Springer の著者は、いずれのサービスも初めて利用する際には10%の割引を受けることができます。以下のリンクを参照ください。
영어 원고의 경우, 에디터 및 리뷰어들이 귀하의 원고에 실린 결과물을 정확하게 평가할 수 있도록, 그들이 충분히 이해할 수 있을 만한 수준으로 작성되어야 합니다. 만약 영작문과 관련하여 도움을 받기를 원하신다면 다음의 사항들을 고려하여 주십시오:
• 귀하의 원고의 표현을 명확히 해줄 영어 원어민 동료를 찾아서 리뷰를 의뢰합니다.
• 영어 튜토리얼 페이지에 방문하여 영어로 글을 쓸 때 자주하는 실수들을 확인합니다.
• 리뷰에 대비하여, 원고의 의미를 명확하게 해주고 리뷰에서 요구하는 문제점들을 식별해서 영문 수준을 향상시켜주는 전문 영문 교정 서비스를 이용합니다. Nature Research Editing Service와 American Journal Experts에서 저희와 협약을 통해 서비스를 제공하고 있습니다. Springer 저자들이 본 교정 서비스를 첫 논문 투고를 위해 사용하시는 경우 10%의 할인이 적용되며, 아래의 링크를 통하여 확인이 가능합니다.
영문 교정 서비스는 게재를 위한 요구사항은 아니며, 해당 서비스의 이용이 피어 리뷰에 논문이 선택되거나 게재가 수락되는 것을 의미하거나 보장하지 않습니다.
원고가 수락될 경우, 출판 전 저희측 편집자에 의해 원고의 철자 및 문체를 검수하는 과정을 거치게 됩니다.